Angiotrofin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 21 USDMF, 8 CEP/COS, 5 JDMF, 6 EU WC, 6 KDMF, 16 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

367 FDF Dossiers, 234 FDA Orange Book, 18 Europe, 87 Canada, 7 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 120MG, TABLET;ORAL - 30MG, TABLET;ORAL - 60MG, TABLET;ORAL - 90MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 420MG, TABLET, EXTENDED RELEASE;ORAL - 120MG, TABLET, EXTENDED RELEASE;ORAL - 180MG, TABLET, EXTENDED RELEASE;ORAL - 240MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 360MG, TABLET, EXTENDED RELEASE;ORAL - 420MG

RELATED EXCIPIENT COMPANIES

14 Evonik, 3 Rochem International Inc, 20 SPI Pharma, 13 DKSH, 6 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 32 BASF, 1 CD Formulation, 22 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 33 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 57 Controlled & Modified Release, 45 Thickeners and Stabilizers, 40 Solubilizers, 36 Direct Compression, 33 Granulation, 31 Taste Masking, 28 Film Formers & Plasticizers, 24 Parenteral, 23 Disintegrants & Superdisintegrants, 20 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 17 Topical, 16 Co-Processed Excipients, 11 Rheology Modifiers, 11 Emulsifying Agents, 9 Empty Capsules, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

37 News #PharmaBuzz

37 News #PharmaBuzz

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 63 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

13 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

25 Health Canada Patents

25 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Zydus Gets USFDA Approval for Diltiazem Hydrochloride Tablets

11 Aug 2025

// INDPHARMAPOST

Zydus`s Generics Diltiazem Hydrochloride Receives Approval in US

08 Aug 2025

// FDA

Novast’s Generics Diltiazem Hydrochloride Approved in US

02 Jul 2025

// FDA

AMTA`s Generics Diltiazem HCl Receives Approval in US

24 Mar 2025

// FDA

Enforcement Report - Week of December 11, 2024

11 Dec 2024

// FDA

Alembic Pharma gets FDA nod for Diltiazem HCl ER capsules

11 Nov 2024

// BUSINESS STD

Angiotrofin

Angiotrofin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

21 USDMF

8 CEP/COS

5 JDMF

6 EU WC

6 KDMF

16 NDC API

24 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

367 FDF Dossiers

234 FDA Orange Book

18 Europe

87 Canada

7 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 120MG

TABLET;ORAL - 30MG

TABLET;ORAL - 60MG

TABLET;ORAL - 90MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 420MG

TABLET, EXTENDED RELEASE;ORAL - 120MG

TABLET, EXTENDED RELEASE;ORAL - 180MG

TABLET, EXTENDED RELEASE;ORAL - 240MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 360MG

TABLET, EXTENDED RELEASE;ORAL - 420MG

RELATED EXCIPIENT COMPANIES

14 Evonik

3 Rochem International Inc

20 SPI Pharma

13 DKSH

6 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

2 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

10 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

32 BASF

1 CD Formulation

22 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

12 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

5 Kima Chemical

CAPSULE, EXTENDED RELEASE;ORAL - 120MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 180MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 240MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons